Follow
Raktim K Ghosh MD FACP FASE FACC
Raktim K Ghosh MD FACP FASE FACC
MedStar Heart and Vascular Institute
Verified email at medstar.net
Title
Cited by
Cited by
Year
COVID-19 pandemic: cardiovascular complications and future implications
D Bandyopadhyay, T Akhtar, A Hajra, M Gupta, A Das, S Chakraborty, ...
American Journal of Cardiovascular Drugs 20, 311-324, 2020
1422020
Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week
S Ball, RK Ghosh, S Wongsaengsak, D Bandyopadhyay, GC Ghosh, ...
Journal of the American College of Cardiology 74 (13), 1714-1727, 2019
1382019
SGLT2 inhibitors: a new emerging therapeutic class in the treatment of type 2 diabetes mellitus
RK Ghosh, SM Ghosh, S Chawla, SA Jasdanwala
The Journal of Clinical Pharmacology 52 (4), 457-463, 2012
1152012
Perception, attitude and usage of complementary and alternative medicine among doctors and patients in a tertiary care hospital in India
V Roy, M Gupta, RK Ghosh
Indian Journal of Pharmacology 47 (2), 137-142, 2015
1112015
Specific antidotes against direct oral anticoagulants: a comprehensive review of clinical trials data
R Tummala, A Kavtaradze, A Gupta, RK Ghosh
International journal of cardiology 214, 292-298, 2016
1102016
Depression in heart failure: Intricate relationship, pathophysiology and most updated evidence of interventions from recent clinical studies
RK Ghosh, S Ball, V Prasad, A Gupta
International journal of cardiology 224, 170-177, 2016
1022016
Recent advances in antiretroviral drugs
RK Ghosh, SM Ghosh, S Chawla
Expert opinion on pharmacotherapy 12 (1), 31-46, 2011
832011
Cardiovascular outcomes of sodium-glucose cotransporter 2 inhibitors: a comprehensive review of clinical and preclinical studies
RK Ghosh, D Bandyopadhyay, A Hajra, M Biswas, A Gupta
International journal of cardiology 212, 29-36, 2016
712016
The 2‐year cost‐effectiveness of 3 options to treat lumbar spinal stenosis patients
BL Udeh, S Costandi, JE Dalton, R Ghosh, H Yousef, N Mekhail
Pain Practice 15 (2), 107-116, 2015
522015
Cost of inpatient heart failure care and 30-day readmissions in the United States
CS Kwok, D Abramov, P Parwani, RK Ghosh, M Kittleson, FZ Ahmad, ...
International journal of cardiology 329, 115-122, 2021
502021
Safety and efficacy of extremely low LDL-cholesterol levels and its prospects in hyperlipidemia management
D Bandyopadhyay, A Qureshi, S Ghosh, K Ashish, LR Heise, A Hajra, ...
Journal of lipids 2018, 2018
492018
Novel emerging therapies in atherosclerosis targeting lipid metabolism
M Gupta, C Blumenthal, S Chatterjee, D Bandyopadhyay, V Jain, ...
Expert Opinion on Investigational Drugs 29 (6), 611-622, 2020
452020
Comparison of three techniques for ultrasound-guided femoral nerve catheter insertion: a randomized, blinded trial
E Farag, A Atim, R Ghosh, M Bauer, T Sreenivasalu, M Kot, A Kurz, ...
Anesthesiology 121 (2), 239-248, 2014
452014
RVX 208: a novel BET protein inhibitor, role as an inducer of apo A‐I/HDL and beyond
GC Ghosh, R Bhadra, RK Ghosh, K Banerjee, A Gupta
Cardiovascular Therapeutics 35 (4), e12265, 2017
432017
Serelaxin in acute heart failure: most recent update on clinical and preclinical evidence
RK Ghosh, K Banerjee, R Tummala, S Ball, K Ravakhah, A Gupta
Cardiovascular therapeutics 35 (1), 55-63, 2017
432017
An update on pharmacotherapies in diabetic dyslipidemia
M Gupta, R Tummala, RK Ghosh, C Blumenthal, K Philip, ...
Progress in cardiovascular diseases 62 (4), 334-341, 2019
422019
Effect of addition of either sitagliptin or pioglitazone in patients with uncontrolled type 2 diabetes mellitus on metformin: A randomized controlled trial
S Chawla, N Kaushik, NP Singh, RK Ghosh, A Saxena
Journal of Pharmacology and Pharmacotherapeutics 4 (1), 27-32, 2013
422013
Sodium glucose co-transporter 2 inhibitors and heart failure
RK Ghosh, GC Ghosh, M Gupta, D Bandyopadhyay, T Akhtar, ...
The American Journal of Cardiology 124 (11), 1790-1796, 2019
392019
Gout pharmacotherapy in cardiovascular diseases: a review of utility and outcomes
S Kaul, M Gupta, D Bandyopadhyay, A Hajra, P Deedwania, E Roddy, ...
American Journal of Cardiovascular Drugs, 1-14, 2020
332020
Cardiovascular outcomes of PCSK9 inhibitors: with special emphasis on its effect beyond LDL-cholesterol lowering
D Bandyopadhyay, K Ashish, A Hajra, A Qureshi, RK Ghosh
Journal of Lipids 2018, 2018
322018
The system can't perform the operation now. Try again later.
Articles 1–20